Podcasts about Median

Češi považují za nejvážnější problém českého školství nedostatečné kapacity mateřských škol. V průzkumu agentury Median pro Radiožurnál a Český rozhlas Plus se na tom shodlo začátkem května přes 80 procent z 1000 respondentů. Co by s tím udělali politici? „Není to o tom, že by se nestavělo. Pomohla by větší koordinace obcí, které jsou ve své bezprostřední blízkosti. Stálo by za to i odbourat byrokracii, aby mohly vznikat dětské skupiny,“ říká Matěj Gregor (Motoristé sobě).

Téměř všichni Češi chtějí, aby škola děti připravila na výzvy budoucnosti a naučila je kritickému myšlení, uvádí průzkum agentury Median pro Radiožurnál a Český rozhlas Plus. Jak připravit děti na měnící se svět? „Bylo by lepší, kdybychom se vrátili k jednotným osnovám a měli více pod kontrolou, co se ve školách vyučuje. Rámcové vzdělávací programy jsou nekoncepční a dávají možnost zasahovat do výuky třeba různým neziskovým organizacím,“ říká Petra Prokšanová (Stačilo!).

Welcome to the latest Bay Area Housing Market Update for May 2025!

Welcome to the "Saturday Morning Golf Stat" from the Hack it Out Golf Podcast. You've missed the green in the rough, but you're still hoping to get up and down and save a score. How far are you likely to end up from the hole when you're 35 yards away and in the rough? In this episode, Lou quizzes Mark and Greg on median distance by handicap. Afterwards, they reiterate why you need to be aware of what a good shot really is—and how expectation management can increase your performance on the course. Each of these will be a mini-episode (10-15 minutes long) about an interesting golf stat. We will discuss what you can learn, and most importantly, how you can apply this on the golf course to lower your scores and lower your handicap. Listen on your drive to the golf course or over your Saturday morning coffee! Data is sourced from Arccos Golf. They have over 1 BILLION shots in their database.  Check them out at: https://www.arccosgolf.com/  Use code DATALOU15 for 15% off! Learn more about your ad choices. Visit megaphone.fm/adchoices

Picking up from their previous discussion on the rise of million-dollar HDBs, George, Alfred, and Joan from PropertyLimBrothers return to discuss what buyers should watch for in 2025. They talked how current price trends—defined by ongoing cooling measures—are influencing buying power and long-term plans. Find out what they think about why prices in the OCR have surged, what's fuelling demand in the RCR, and how new launches are being priced island-wide.   Also, Joan shares why she believes it's better to act early, while Alfred outlines the logic behind starting with a two-bedder. They also touch on how to manage FOMO, read the shifts in policy, and stay grounded despite market noise. If you're trying to decide whether to buy, wait, or pivot—this episode offers clear, timely insight to help guide your next move.   00:00 Introduction 00:40 HDB price trend 03:09 Age always affects you 05:00 Interest rate will drop? 09:00 Future cooling measure scenario 12:22 Median age of buyers (New Private Home) 14:30 Advice for first time home owners 17:58 Median profit 18:30 Prices of private property market 25:42 RCR having more demand 28:30 Hottest new launches today 29:30 New Launch important things to take note 36:42 Upcoming New Launches 40:50 Closing 41:55 Outtakes

Host Dr. Davide Soldato and guest Dr. Harriet Kluger discuss the JCO article "Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases." Transcript The guest on this podcast episode has no disclosures to declare. Dr. Davide Soldato Hello and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, Medical Oncologist at Ospedale San Martino in Genoa, Italy. Today, we are joined by JCO author Dr. Harriet Kluger. Dr. Kluger is a professor of medicine at Yale School of Medicine, Director of the Yale SPORE in Skin Cancer, and an internationally recognized expert in immuno-oncology for melanoma and renal cell carcinoma. She leads early-phase and translational trials that pair novel immunotherapies with predictive biomarkers to personalized care. Today, Dr. Kluger and I will be discussing the article titled "Phase 2 Trial of Pembrolizumab in Combination with Bevacizumab for Untreated Melanoma Brain Metastases." In this study, Dr. Kluger and colleagues evaluated four cycles of pembrolizumab plus the anti-VEGF antibody bevacizumab followed by pembrolizumab maintenance in patients with asymptomatic non-hemorrhagic melanoma brain metastases that had not previously received PD-1 therapy. Thank you for speaking with us, Dr. Kluger. Dr. Harriet Kluger Thank you for inviting me. The pleasure is really all mine. Dr. Davide Soldato So to kick off our podcast, I just wanted to ask if you could outline a little bit the biological and clinical rationale that led you to test this type of combination for patients with untreated brain metastases from metastatic melanoma. Dr. Harriet Kluger Back in approximately 2012, patients who had untreated brain metastases were excluded from all clinical trials. So by untreated, I mean brain metastases that had not received local therapy such as surgery or radiation. The reason for it was primarily because there was this fear that big molecules wouldn't penetrate brain lesions because they can't pass the blood-brain barrier. Turns out that the blood-brain barrier within a tumor is somewhat leaky and drugs sometimes can get in there. When PD-1 inhibitors were first identified as the next blockbuster class of drugs, we decided to conduct a phase 2 clinical trial of pembrolizumab monotherapy in patients with untreated brain metastases. We actually did it also in lung cancer, and we could talk about that later on. Responses were seen. The responses in the brain and the body were similar. They were concordant in melanoma patients. Now, at approximately that time, also another study was done by the Australian group by Dr. Georgina Long, where they did a randomized trial where patients who didn't require immediate steroid therapy received either nivolumab alone or nivolumab with ipilimumab, and the combination arm was substantially superior. Subsequently, also, Bristol Myers Squibb also conducted a large phase 2 multicenter trial of ipilimumab and nivolumab in patients with untreated brain metastases. And there, once again, they saw that the responses in the brain were similar to the responses in the body. Now, somewhere along the line there, we completed our anti-PD-1 monotherapy trial. And when we looked at our data, we still didn't have the data on ipilimumab and nivolumab. And our question was, “Well, how can we do better?” Just as we're always trying to do better. We saw two really big problems. One was that patients had a lot of perilesional edema. And the other one was that we were struggling with radiation necrosis in lesions that were previously Gamma Knifed. The instance of radiation necrosis was in excess of 30%. So the rationale behind this study was that if we added bevacizumab, maybe we could treat those patients who had some edema, not requiring steroids, but potentially get them on study, get that PD-1 inhibitor going, and also prevent subsequent radiation necrosis. And that was the main rationale behind the study. We had also done some preclinical work in mouse models of melanoma brain metastases and in an in vitro blood-brain barrier model where we showed that bevacizumab, or anti-VEGF, really tightens up those leaky basement membranes and therefore would be very likely to decrease the edema. Dr. Davide Soldato Thank you very much for putting in context the combination. So this was a phase 2 trial, and you included patients who had at least one lesion, and you wanted lesions that were behind 5 and 20 millimeters. Patients could be included also if the brain metastasis was higher in dimension than 20 millimeters, but it had to be treated, and it was then excluded from the evaluation of the primary objective of the trial. So regarding, a little bit, these characteristics, do you think that this is very similar to what we see in clinical practice? And what does this mean in terms of applicability of these results in clinical practice? Dr. Harriet Kluger So that's an excellent question. The brain metastasis clinical research field has somewhat been struggling with this issue of inclusion/exclusion criteria. When we started this, we showed pretty clearly that 5 to 10 millimeter lesions, which are below the RECIST criteria for inclusion, are measurable if you use MRIs with slices that are 1 to 2 millimeters. Most institutions in the United States do use these high-resolution MRIs. I don't know how applicable that is on a worldwide scale, but we certainly lowered the threshold for inclusion so that patients who have a smattering of small brain metastases would be eligible. Now, patients with single large brain metastases, the reason that we excluded those from the trial was because we were afraid that if a patient didn't respond to the systemic therapy that we were going to give them, they could really then develop severe neurological symptoms. So, for patient safety, we used 20 millimeters as the upper level for inclusion. Some of the other trials that I mentioned earlier also excluded patients with very large lesions. Now, in practice, one certainly can do Gamma Knife therapy to the large lesions and leave the smaller ones untreated. So I think it actually is very applicable to clinical practice. Dr. Davide Soldato Thank you very much for that insight, because I think that sometimes criteria for clinical trials, they have to be very restrictive. But then we know that in clinical practice, the applicability of these results is probably broader. So, going a little bit further in the results of the study, I just wanted a little bit of comment from you regarding what you saw in terms of intracranial response rate and duration of response among patients who obtained a response from the combination treatment. Dr. Harriet Kluger So we were actually surprised. When we first designed this study, as I said earlier, we weren't trying to beat out ipilimumab and nivolumab. We were really just trying to exclude those patients who wouldn't have otherwise been eligible for ipilimumab and nivolumab because of edema or possibly even previous radiation necrosis. So it was designed to differentiate between a response rate of 34%, and I believe the lower bound was somewhere in the 20s, because that's what we'd seen in the previous pembrolizumab study. What we saw in the first 20 patients that we enrolled was actually a response rate that far exceeded that. And so we enrolled another cohort to verify that result because we were concerned about premature publishing of a result that we might have achieved just by chance. The two cohorts were very similar in terms of the response rates. And certainly this still needs to be verified in a second study with additional institutions. We did include the Moffitt Cancer Center, and the response rate with Moffitt Cancer Center was very similar to the Yale Cancer Center response rate. Now, your other question was about duration of response. So the other thing that we started asking ourselves was whether this high response rate was really because the administration of the anti-VEGF will decrease the gadolinium enhancement and therefore we might actually just be seeing prettier scans but not tumor shrinkage. And the way to differentiate those two is by looking at the duration of the response. Median progression-free survival was 2.2 years. That's pretty long. The upper bound on the 95% confidence interval was not reached. I can't tell you that the duration is as good as the duration would be when you give ipilimumab. Perhaps it is less good. This was a fairly sick population of patients, and it included some who might not have been able to receive ipilimumab and nivolumab. So it provides an alternative. I do believe that we need to do a randomized trial where we compare it to ipilimumab and nivolumab, which is the current standard of care in this patient population. We do need to interpret these results with caution. I also want to point out regarding the progression-free survival that we only gave four doses of anti-VEGF. So one would think that even though anti-VEGF has a long half-life of three or four weeks, two years later, you no longer have anti-VEGF effect, presumably. So it does something when it's administered fairly early on in the course of the treatment. Dr. Davide Soldato So, in terms of clinical applicability, do you see this combination of pembrolizumab and bevacizumab - and of course, as we mentioned, this was a phase 2 trial. The number of patients included was not very high, but still you saw some very promising results when compared with the combination of ipilimumab and nivolumab. So do you see this combination as something that should be given particularly to those patients who might not be able to receive ipilimumab and nivolumab? So, for example, patients who are very symptomatic from the start or require a high dose of steroids, or also to provide a quicker response in terms of patients who have neurological symptoms, or do you think that someday it could be potentially used for all patients? Dr. Harriet Kluger The third part of your question, whether it can be used someday for all patients: I think we need to be very careful when we interpret these results. The study was substantially smaller than the ipilimumab/nivolumab trial that was conducted by Bristol Myers Squibb. Also going to point out that was a different population of patients. Those were all frontline patients. Here we had a mix of patients who'd had previous anti-CTLA-4 and frontline patients. So I don't think that we can replace ipilimumab and nivolumab with these results. But certainly the steroid-sparing aspect of it is something that we really need to take into consideration. A lot of patients have lesions in locations where edema can be dangerous, and some of them have a hard time coming off the steroids. So this is certainly a good approach for those folks. Dr. Davide Soldato And coming back to something that you mentioned in the very introduction, when you said that there were two main problems, which was one, the problem of the edema, and the second one, the problem of the radionecrosis. In your trial, there was a fair percentage of patients who received some type of local treatment before the systemic one. So the combination of pembrolizumab and bevacizumab. And most of the patients received radiosurgery. So I just wanted a brief comment regarding the incidence of radionecrosis in the trial and whether that specific component of the combination with bevacizumab was reduced. And how do you think that this fares in terms of what we see in clinical practice in terms of radionecrosis? Dr. Harriet Kluger I'm not sure that we really reduced the incidence of radiation necrosis. We saw radiation necrosis here. We saw less of it than in the trial of pembrolizumab monotherapy, but these were also different patients, different time. We saw more than we thought that we were going to see. It was 27%, I believe, which is fairly high still. We only gave the four doses of bevacizumab. Maybe to really prevent radiation necrosis, you have to continue to give the bevacizumab. That, too, needs to be tested. The reason that we gave the four doses of bevacizumab was simply because of the cost of the bevacizumab at the time. Dr. Davide Soldato Thank you very much for that comment on radionecrosis. And I really think that potentially this is a strategy, so continuing the bevacizumab, that really makes a lot of sense, especially considering that the tolerability of the regimen was really very, very good, and you didn't see any significant or serious adverse events related to bevacizumab. So just wondering if you could comment a little bit on the toxicities, whether you had anything unexpected. Dr. Harriet Kluger There was one patient who had a microperforation of a diverticulum, which was probably related to the bevacizumab. It was conservatively managed, and the patient did fine and actually remains alive now, many years later. We had one patient who had dehiscence of a previous wound. So there is some. We did not see any substantial hypertension, proteinuria, but we only gave the four doses. So it is possible that if you give it for longer, we would see some side effects. But still, relative to ipilimumab, it's very, very well tolerated. Dr. Davide Soldato Yeah, exactly. I think that the safety profile is really different when we compare the combination of ipilimumab/nivolumab with the pembrolizumab/bevacizumab. And as you said, this was a very small trial and probably we need additional results. But still, these results, in terms of tolerability and safety, I think they are very interesting. So one additional question that I think warrants a little bit of comment on your part is actually related to the presence of patients with BRAF mutation and, in general, to what you think would be the best course of treatment for these patients who present with the upfront brain metastases. So this, it's actually not completely related to the study, but I think that since patients with BRAF mutation were included, I think that this warrants a little bit of discussion on your part. Dr. Harriet Kluger So we really believe that long-term disease control, particularly in brain metastases, doesn't happen when you give BRAF/MEK inhibitors. You sometimes get long-term control if you've got oligometastatic disease in extracranial sites and if they've previously been treated with a lot of immune checkpoint inhibitors, which wasn't the case over here. So a patient who presents early in the course of the disease, regardless of their BRAF status, I do believe that between our studies and all the studies that have been done on immunotherapy earlier in the course of disease, we should withhold BRAF/MEK inhibitors unless they have overwhelming disease and we need immediate disease control, and then we switch them very quickly to immunotherapy. Can I also say something about the toxicity question from the bevacizumab? I have one more comment to make. I think it's important. We were very careful not to include patients who had overt hemorrhage from brain metastases. So melanoma brain metastases relative to other tumor types tend to bleed, and that was an exclusion criteria. We didn't see any bleeding that was attributable to the bevacizumab, but we don't know for sure that, if this is widely used, that that might not be a problem that's observed. So I would advise folks to use extreme caution and perhaps not use it outside of the setting of a clinical trial in patients with overt hemorrhage in the melanoma brain metastases. Dr. Davide Soldato Thank you very much. I think that one aspect that is really interesting in the trial is actually related to the fact that you collected a series of biomarkers, both circulating ones, but also some that were collected actually from the tissue. So just wondering if you could explain a little bit which type of biomarkers you evaluated and whether you saw any significant results that could suggest higher or lower efficacy of the combination. Dr. Harriet Kluger Thank you for that. So yes, the biomarker studies are fairly exploratory, and I want to emphasize that we don't have anything that's remotely useful in clinical practice at this juncture. But we did see an association between vessel density in the tumors and improved response to this regimen. So possibly those lesions that are more vascular are more fed by or driven by VEGF, and that could be the reason that there was improved response. We also saw that when there was less of an increase in circulating angiopoietin-2 levels, patients were more likely to respond. Whether or not that pans out in larger cohorts of patients remains to be determined. Dr. Davide Soldato Still, do you envision validation of these biomarkers in a potentially additional trial that will evaluate, again, the combination? Because I think that the signals were quite interesting, and they really make sense from a biological point of view, considering the mechanism of action of bevacizumab. So I think that, yeah, you're right, they are exploratory. But still, I think that there is very strong biological rationale. So really I wanted to congratulate you on including that specific part and on reporting it. And so the question is, really, do you envision validation of these biomarkers in larger cohorts? Dr. Harriet Kluger I would hope to see that, just as I'd like to see validation of the clinical results as well. The circulating biomarkers are very easy to do. It's a simple ELISA test. And the vessel density on the tumor is essentially CD34 staining and units per area of tumor. Also very simple to do. So I'd love to see that happen. Dr. Davide Soldato Do you think that considering the quality of the MRI that we are using right now, it would be possible to completely bypass even the evaluation on the tissue? Like, are we going in a direction where we can, at a certain point, say the amount of vessels that we see in these metastases is higher versus lower just based on MRI results? Dr. Harriet Kluger You gave me an outstanding idea for a follow-up study. I don't know whether you can measure the intensity of gadolinium as a surrogate, but certainly something worth asking our neuroradiology colleagues. Excellent idea. Thank you. Dr. Davide Soldato You're welcome. So just moving a step further, we spoke a lot about the validation of these results and the combination. And just wanted your idea on what do you think it would be more interesting to do: if designing a clinical trial that really compares pembrolizumab/bevacizumab with ipilimumab and nivolumab or going directly for the triplet. So we know that there has been some type of exploration of triplet combination in metastatic melanoma. So just your clinical impression: What would you do as an investigator? Dr. Harriet Kluger So it's under some discussion, actually. It's very difficult to compare drugs from different companies in an investigator-initiated trial. Perhaps our European colleagues can do that trial for us. In the United States, it's much harder, but it can be done through the cooperative groups, and we are actually having some discussions about that. I don't have the answer for you. It would be lovely to have a trial that compared the three drugs to ipi/nivo and to pembrolizumab/bevacizumab. So a three-arm trial. But remember, these are frontline melanoma patients. There aren't that many of them anymore like there used to be. So accrual will be hard, and we have to be practical. Dr. Davide Soldato Yeah, you're right. And in the discussion of the manuscript, you actually mentioned some other trials that are ongoing, especially one that is investigating the combination of pembro and lenvatinib, another one that is investigating the combination of nivolumab and relatlimab. So just wondering, do you think that the molecule in terms of VEGF inhibition, so bevacizumab versus lenvatinib, can really make a difference or is going to be just a mechanism of action? Of course, we don't have the results from this trial but just wondering if you could give us a general comment or your opinion on the topic. Dr. Harriet Kluger So that's a really great question. The trial of pembrolizumab and lenvatinib was our answer to the fact that bevacizumab is not manufactured by the same company as pembrolizumab, and we're trying to give a practical answer to our next study that might enable us to take this approach further. But it does turn out from our preclinical studies that bevacizumab and VEGF receptor inhibition aren't actually the same thing in terms of the effects on the blood-brain barrier or the perilesional tumor microenvironment in the brain. And these studies were done in mice and in in vitro models. Very different effects. The lenvatinib has stronger effect on the tumors themselves, the tumor cells themselves, than the bevacizumab, which has no effect whatsoever. But the lenvatinib doesn't appear to tighten up that blood-brain barrier. Dr. Davide Soldato Thank you. I think that's very interesting, and I think it's going to be interesting to see also results of these trials to actually improve and give more options to our patients in terms of different mechanism of action, different side effects. Because in the end, one thing that we discussed is that some combination may be useful in some specific clinical situation while others cannot be applicable, like, for example, an all immunotherapy-based combination. Just one final comment, because I think that we focused a lot on the intracranial response and progression-free survival. You briefly mentioned this but just wanted to reinforce the concept. Did you see any differences in terms of intracranial versus extracranial response for those patients who also had extracranial disease with the combination of pembro and bevacizumab? Dr. Harriet Kluger So the responses were almost always concordant. There were a couple of cases that might have had a body response and not an intracranial response and vice-versa, but the vast majority had concordant response or progression. We do believe that it's a biological phenomenon. The type of tumor that tends to go to the brain is going to be the type of tumor that will respond to whatever the regimen is that we're giving. In the previous trial also, we saw concordance of responses in the body and the brain. Dr. Davide Soldato Thank you very much. Just to highlight that really the combination is worth pursuing considering that there was not so much discordant responses, and the results, even in a phase 2 trial, were very, very promising. So thank you again, Dr. Kluger, for joining us today and giving us a little bit of insight into this very interesting trial. Dr. Harriet Kluger Thank you for having me. Dr. Davide Soldato So we appreciate you sharing more on your JCO article titled "Phase 2 Trial of Pembrolizumab in Combination with Bevacizumab for Untreated Melanoma Brain Metastases," which gave us the opportunity to discuss current treatment landscape in metastatic melanoma and future direction in research for melanoma brain metastasis. If you enjoy our show, please leave us a rating and review and be sure to come back for another episode. You can find all ASCO shows at asco.org/podcasts.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

We talk to Alex and Victoria Fleri on the Gold Coast Surfers Paradise has officially entered the $4 million club, with median house prices skyrocketing 123% in just five years. In this video, we unpack the luxury property boom reshaping the Gold Coast and why elite buyers are rushing in. Listen here: https://apple.co/3wub8Le ► Subscribe here to never miss an episode: https://www.podbean.com/user-xyelbri7gupo ► INSTAGRAM: https://www.instagram.com/therealestatepodcast/?hl=en  ► Facebook: https://www.facebook.com/profile.php?id=100070592715418 ► Email:  myrealestatepodcast@gmail.com    The latest real estate news, trends and predictions for Brisbane, Adelaide, Canberra, Gold Coast, Sydney, Melbourne and Perth. We include home buying tips, commercial real estate, property market analysis and real estate investment strategies. Including real estate trends, finance and real estate agents and brokers. Plus real estate law and regulations, and real estate development insights. And real estate investing for first home buyers, real estate market reports and real estate negotiation skills. We include Hobart, Darwin, Hervey Bay, the Sunshine Coast, Newcastle, Central Coast, Wollongong, Geelong, Townsville, Cairns, Ballarat, Bendigo, Launceston, Mackay, Rockhampton, Coffs Harbour. #AustralianRealEstate  #QLDProperty #HomeBuyingTips #MortgageBroker #PerthRealEstate #SavingForAHome  #SmartInvesting #PropertyMarketUpdate #BrisbaneHomes #PerthProperty #FirstHomeBuyers #FinanceTips #RealEstateNews #HousingMarket #InvestingInProperty   #MortgageTips #SydneyLiving  #sydneyproperty #Melbourneproperty #brisbaneproperty #perthproperty #goldcoast #adelaideproperty #canberraproperty #sunshinecoastproperty #cairnsproperty #hobartproperty #darwinproperty #PropertyUpdate  #InvestmentOpportunities #AffordableHousing  #RealEstateAustralia  #SurfersParadise #GoldCoastRealEstate #LuxuryProperty #PropertyBoom #AustraliaHousingMarket

Darwin just posted the highest monthly property price jump across all capitals at 1.1%, with a 4.1% annual increase. Median house prices now sit at $602K. We talk with Will Johnson from Herron Todd White in Darwin about what's driving this growth and how infrastructure investment is transforming the Top End. Listen here: https://apple.co/3wub8Le ► Subscribe here to never miss an episode: https://www.podbean.com/user-xyelbri7gupo ► INSTAGRAM: https://www.instagram.com/therealestatepodcast/?hl=en  ► Facebook: https://www.facebook.com/profile.php?id=100070592715418 ► Email:  myrealestatepodcast@gmail.com    The latest real estate news, trends and predictions for Brisbane, Adelaide, Canberra, Gold Coast, Sydney, Melbourne and Perth. We include home buying tips, commercial real estate, property market analysis and real estate investment strategies. Including real estate trends, finance and real estate agents and brokers. Plus real estate law and regulations, and real estate development insights. And real estate investing for first home buyers, real estate market reports and real estate negotiation skills. We include Hobart, Darwin, Hervey Bay, the Sunshine Coast, Newcastle, Central Coast, Wollongong, Geelong, Townsville, Cairns, Ballarat, Bendigo, Launceston, Mackay, Rockhampton, Coffs Harbour. #AustralianRealEstate  #QLDProperty #HomeBuyingTips #MortgageBroker #PerthRealEstate #SavingForAHome  #SmartInvesting #PropertyMarketUpdate #BrisbaneHomes #PerthProperty #FirstHomeBuyers #FinanceTips #RealEstateNews #HousingMarket #InvestingInProperty   #MortgageTips #SydneyLiving #Parramatta  #sydneyproperty #Melbourneproperty #brisbaneproperty #perthproperty #goldcoast #adelaideproperty #canberraproperty #sunshinecoastproperty #cairnsproperty #hobartproperty #darwinproperty #PropertyUpdate #OrangeRealEstate #InvestmentOpportunities #AffordableHousing #OrangeNSW #RealEstateAustralia  

When is the right time to buy a home? For many, it's when they feel ready—personally and financially. But even then, timing the market, understanding future price direction, and interpreting shifting economic signals can complicate the decision. In this episode, we break down everything you need to know to make a confident, informed choice about buying a home in 2025.First, we examine the all-powerful & predominant force of interest rates. The Bank of Canada held steady in April, but with two more rate cuts expected in June and September, we could see the overnight rate drop to 2.25% by year-end. Variable-rate holders may feel relief by the fall, while fixed rates have remained mostly unchanged—making the 3.99% offers available now historically attractive, even if there's potential for further dips.But rates don't act alone. Sentiment plays a massive role. Despite consumer confidence hitting all-time lows, April brought a slight rebound—too soon to call it a trend. However, business sentiment continues to deteriorate, dragging down the Real Estate Outlook Index at its fastest pace since the 2022 rate shock. Sales volumes remain sluggish, and we don't expect a sharp bounce anytime soon.Real estate moves in cycles, and Vancouver's decades-long climb may be entering a slower phase. We revisit Toronto's 1989 peak, when prices fell 27% over seven years and took 22 years to recover in inflation-adjusted dollars. Could Vancouver follow a similar path after peaking in 2022? If so, prices may not reach those highs again until 2028 or later. Buying today means thinking long-term—and accepting that appreciation might not arrive on your timeline.Meanwhile, first-time buyers are getting older. In Canada, the average is now 33—up from 32 in the early '80s—while in Ontario it's hit 40. Surprisingly, Americans, with cheaper homes but more student debt, wait even longer (age 38 on average). What's driving Canadians to buy sooner? But supply is failing to keep up. March housing starts missed expectations by 14%, and condo construction is in freefall—down 45% from last year. Remove purpose-built rentals, and we're at 15-year lows. Ontario and BC, the provinces with the greatest need, are down 38% and 30% year-over-year. CMHC says we need 3.1 million more homes by 2030. At this rate, that's a pipe dream.On top of that, inventory levels are rising, especially in the pre-sale market. Vancouver could hit 3,500 unsold new condos by year-end—a 60% surge. With investor demand almost vanished (down from 50%, then 25% and now 7%!), developers are cancelling projects, and hundreds of homes won't break ground. Even with record immigration—Toronto just became North America's fastest-growing city—new supply is evaporating.We close with a mini-market update: May sales in Vancouver are trending at a six-year low (outside of COVID lockdowns), while inventory is at an 11-year high. Median prices are up slightly, but average prices are slipping. Could this be the inflection point?So… is now the right time to buy? That depends on your goals, your timeline, and your outlook. This episode delivers the data, trends, and insights to help you decide—with eyes wide open.Are you prepared to buy with the long-term in mind, even if prices don't rise during your ownership? Let's chat about it. _________________________________ Contact Us To Book Your Private Consultation:

Listen to #Pulse95Radio in the UAE by tuning in on your radio (95.00 FM) or online on our website: www.pulse95radio.com ************************ Follow us on Social. www.instagram.com/pulse95radio www.facebook.com/pulse95radio www.twitter.com/pulse95radio

Väliriihi onnistui | Kangasharju Kujanpää | #neuvottelija 327. Aki Kangasharju, ETLA:n toimistujohtaja ja Emmiliina Kujanpää EVA:n veroasiantuntija purkavat historiallisen oikeistolaista hallituksen puoliväliriihipakettia. Siinä on paljon herkkuja, kuten palkan progression lasku korkeintaan 52%-tasolle, 18% yhteisövero, perintö- ja lahjaveron uudistus, 25% veroaste eliittimamuille sekä paljon kasvua tukevia muutoksia yksittäisiin lakikokonaisuuksiin.00:00 Verotus kevenee! Emmiliina Kujanpää ja Aki Kangasharju00:34 Emmiliinan itävaltalainen koulukunta #neuvottelija 32401:11 Aki Kangaharjun Talouden ilmestyskirja #neuvottelija 22901:44 Villapaitaekonomistit ja ideologinen värikynä02:37 Tuloveron progression loiventaminen ja positiviiset vaikutukset03:42 Kansainväliset esimerkit Tanskasta ja Ruotsista04:49 Suomalaismielipiteet ansiotuloveron reiluudesta05:25 Median vasemmistovetoisuus vs. kansan realismi06:00 Hallitusohjelman ja väliriihen ristiriitaisuudet06:31 Risto Murron raportin rajaukset ja kritiikki07:00 Alaikäisten perintöveron helpotukset suunnitteilla07:57 Kansan toiveet ja veropäätösten kansanomaisuus08:29 Luovutusvoittoveron puuttuminen pettymyksenä09:00 Varallisuuserot Ruotsin ja Suomen välillä10:04 VATTin perintöveroanalyysin kapeus ja ongelmallisuus11:08 Sukupolvenvaihdosten esteet ja yrityskauppojen haasteet12:33 Yhteisöveron alennus ja sen kohdistusvaikutus15:09 Byrokratian esteet ja pk-yritysten realiteetit16:01 Veronkorotusriski ja luottamuspulan vaikutus16:54 Verokilpailukykyvertailut Suomi Viro ja Ruotsi18:00 Avainhenkilöveron alennus ja paluumuuttajien asema20:35 Eliittimamut ja verokannustimien tehot22:26 Paluumuuttajien urahaasteet ja verouudistus24:04 Pääomasijoittajat ja omistusrakenteiden pitkäjänteisyys25:37 Säätiöt ja rahastojen verokohtelun helpottaminen27:10 Asuntomarkkinoiden piristyminen ja noususkenaario28:39 Optiot, tulonmuunto ja pääomatulojen merkitys30:10 Osinkoverotus ja listamattomien yritysten tilanne31:41 Yhteisövero vs. osinkovero – dynamiikan säilyttäminen33:14 Poliittinen jatkuvuus ja osinkoveron tulevaisuus34:40 Kansainväliset veroprosenttivertailut ja media36:11 Dynaamisten vaikutusten vähättely ja tutkimusdata37:37 Koulutuspanostukset ja osaajapohjan laajennus39:10 Monipaikkaisuus, sivutyöt ja tuottavuuden kasvu40:48 Ay-jäsenmaksut ja verovähennysten logiikka42:17 Työnantajamaksut ja veropolitiikan tasapuolisuus43:47 Verojärjestöjen rajaukset ja lainsäädännön tarkkuus45:16 Optimismi Suomen suunnasta #neuvottelija Sisäpiiri kertoo mitä eroa on EVA:lla ja ETLA:llaKatso Sisäpirijaksot ja tue Samiahttps://www.youtube.com/channel/UCRI34L9OtDJuZpaWicbNXzg/join#neuvottelija Sami Miettinen

Spokojení s životem ve svém regionu jsou čtyři z pěti Čechů, ukázal exkluzivní průzkum agentury MEDIAN pro Radiožurnál a ČRo Plus. Nejspokojenější jsou obyvatelé Vysočiny a jihu ČR, zato na severu Čech, provázaném s útlumem těžby a navazujícího průmyslu, jen každý třetí z pěti. Horší nabídku pracovních pozic pociťují také obyvatelé u hranic jednotlivých krajů. Jakou zkušenost mají politici s dotačními programy pro rozvoj zaostávajících regionů? A co různé kraje potřebují?

Spokojení s životem ve svém regionu jsou čtyři z pěti Čechů, ukázal exkluzivní průzkum agentury MEDIAN pro Radiožurnál a ČRo Plus. Nejspokojenější jsou obyvatelé Vysočiny a jihu ČR, zato na severu Čech, provázaného s útlumem těžby a navazujícího průmyslu, jen každý třetí z pěti. Horší nabídku pracovních pozic pociťují také obyvatelé u hranic jednotlivých krajů. Jakou zkušenost mají politici s dotačními programy pro rozvoj zaostávajících regionů? A co různé kraje potřebují?

Timo Harrikari, Linda Määttä ja Essi Julin ovat tutkineet, miten lasten, nuorten ja lapsiperheiden asioita on käsitelty eduskunnassa. Heidän tutkimuksensa "Sukupolvipolitiikkaa signaloimassa : Kansanedustajien lapsia, nuoria ja lapsiperheitä käsittelevät eduskuntaesitykset vuosina 1970–2020" mukaan 1990-luvun lopusta lähtien eduskunnassa on alettu puhua enemmän lasten ja nuorten pahoinvoinnista. Miksi? Ja mitä poliitikot signaloivat tehdessään esityksiä lasten, nuorten ja lapsiperheiden asioista, ja kenelle? Lähetyksessä keskustellaan myös siitä, että Suomessa on alettu puhua lapsiperheköyhyyden lisäksi myös lasten ja nuorten mielenterveysongelmista ja päihteiden käytöstä. Länsimaissa, erityisesti Yhdysvalloissa ja Isossa-Britanniassa, on voimakkaasti käsitelty vastaavia aiheita mediassa jo 1980-luvulta alkaen. MIten tämä jatkuva negatiivinen uutisointi on vaikuttanut siihen, miten nuorisopolitiikkaa tehdään ja toteutetaan? Vieraina ovat Helsingin yliopiston sosiaalityön professori Timo Harrikari, Nuorisoala ry:n toiminnanjohtaja Anna Munsterhjelm, Mannerheimin Lastensuojeluliiton vaikuttamistyön johtaja Esa Iivonen ja Tampereen yliopiston nuorisotutkimuksen professori Päivi Honkatukia. Lähetyksen toimittaa Pauliina Grym.

Khatungmani Khorang

In a new report from the Kem C. Gardner Policy Institute showed that Utah's median income is ranked high among other states and middle-income households are earning more on average. Despite this, Utahns are still feeling the pinch of rising prices. Phil Dean, Chief Economist from the Kem C. Gardner Institute joins the show to discuss these findings and if these numbers really matter to the average Utahn.

Will Tariffs Impact the Housing Market? | Cupertino House of the WeekIn this episode, Vito from Abano explores the potential impact of new tariffs on the housing market, emphasizing the regional variations in real estate trends. He provides insights into consumer sentiment, economic uncertainty, and their effects on home prices. The episode also features detailed tours of selected Cupertino and Willow Glen properties, including a luxury home in Atherton. Vito highlights the importance of understanding micro markets and presents market data on Santa Clara County and the Bay Area. Don't miss the detailed property reviews and current real estate trends!Will Tariffs Impact Home Sales in the US?Cupertino Home of the Week Willow Glen Home of the Week Luxury Home of the Week FREE HOME BUYER CHECKLIST HERE https://abitanogroup.com/HomebuyerchecklistHome Inspection CHECKLIST HERE00:00 Introduction: Will Tariffs Impact the Housing Market?00:05 Micro Markets and Regional Variations01:34 Impact on Home Prices and Consumer Sentiment02:59 Regional Housing Market Insights04:10 Cupertino House of the Week05:28 Willow Glen House of the Week07:24 Bay Area Housing Market Report

Send us a textThis week, Teko & McFlei break down Jae Tips' Jazz 9 release rollout, sharing their thoughts on how the weekend played out and the energy behind the drop. The fellas also talk about JD Sports' ultra-limited release of the Air Max 95 Neon "Big Bubble", which hit select shelves overseas and left U.S. fans watching from afar.Patta is stirring the pot again, with leaked images of the upcoming Neon Air Max 90 "Waves" creating buzz ahead of the official drop. The guys also tap into the growing conversation around tariffs and what they could mean for sneaker consumers moving forward.All this and much more on this week's episode of The Sneaker Dads Podcast!Support the show

What will the impact be now that the U.S. has one of the highest tariff rates in the world?Topics covered include:Why the Trump administration raised tariffsHow the last round of U.S. tariffs led to higher prices and lower economic growthFour ways the world remains close to record connectivityWho have been the winners and losers from global tradeWhat will be the impact of this trade warEpisode SponsorsDelete Me – Use code David20 to get 20% offInsiders Guide Email NewsletterGet our free Investors' Checklist when you sign up for the free Money for the Rest of Us email newsletterOur Premium ProductsAsset CampMoney for the Rest of Us PlusShow NotesThe economic consequences of Mr Trump – looking for clarity in the tariffs chaos by Neil Shearing—Capital EconomicsTariff rate, most favored nation, simple mean, all products (%)—World Bank GroupDonald Trump's tariffs will fix a broken system by Peter Navarro—The Financial TimesDHL Global Connectedness Tracker—DHLObjective Knowledge: An Evolutionary Approach by Karl R. Popper—Oxford University PressGDP per capita (constant 2015 US$)—World Bank GroupJOSEPH E. STIGLITZ, GLOBALIZATION AND ITS DISCONTENTS REVISITED: ANTI-GLOBALIZATION IN THE ERA OF TRUMP, NEW YORK: W.W. NORTON & COMPANY, 2018 by Lino Sau—Annals of the Fondazione Luigi EinaudiFIFTY YEARS OF GROWTH IN AMERICAN CONSUMPTION, INCOME, ANDWAGES by Bruce Sacerdote—National Bureau of Economic ResearchReal Median Household Income in the United States—FREDEmployed full time: Median usual weekly real earnings: Wage and salary workers: 16 years and over—FREDConsumer Price Index for All Urban Consumers: Food in U.S. City Average/Median Household Income in the United States—FREDTrump's Love for Tariffs Began in Japan's '80s Boom By Jim Tankersley and Mark Landler—The New York TimesRelated Episodes515: Tariffs and the Mar-a-Lago Accord: What Trump Really Wants516: What Trump Wants Part 2 – How Trade Deficits and Capital Flows Can Harm or Help Countries427: Did the Tariffs Work? The Trade War Five Years Later212: Trade Wars Increase Prices and PovertySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textWashington County's real estate market has shifted to a more balanced position with 4.82 months of inventory, representing a 22% increase from last year, though slight downward pressure on pricing has resulted in only a 2% decrease in average sold prices.• Median sold price of $520,000 shows minimal change from last year at just 1.7% higher• Current 30-year fixed mortgage rate at 6.75%, down from 7.26% in January• Original list price to sold price ratio is 95.9%, indicating sellers are typically getting slightly less than asking• Days on market varies significantly by price point - homes between $400,000-$500,000 sell fastest at 51 days• Migration data shows buyers from areas with higher home values (California, Colorado) find Washington County prices reasonable• Housing market correlation with interest rates appears broken since 2022• Local economy shows greater diversity than pre-2008 recession when construction was 30% of economy• Current unemployment rate remains stable at around 3%Guest Branden DuCharme, CMT, Find Du Charme Wealth Management here:https://ducharmewealth.com/contact-us/Looking for a Real Estate expert? Find us here!https://realestate435.kw.com/www.wealth435.com https://linktr.ee/wealth435 Below are our wonderful friends!Find FS Coffee here:https://fscoffeecompany.com/Find Tuacahn Amphitheater here:https://www.tuacahn.org/Find Blue Form Media here:https://www.blueformmedia.com/#podcast #southernutah #investing #stgeorgeutah #realestate #435podcast #financialmarket #business #affordablehousing #afforadable [00:00:00] Intro.[00:00:48] Washington County Real Estate Overview.[00:08:33] Market Statistics and Current Trends.[00:18:32] Breaking Down Price Points and Days on Market.[00:27:46] The Conflict of Interest in Real Estate.[00:38:35] Home Value Comparisons Across States.[00:47:33] Employment Data and Economic Diversity.[00:57:46] Final Thoughts and Episode Wrap-Up.

How Is Living in Maine Different Than Visiting?Maine is one of the most beautiful states in the country—and if you've ever visited, you probably already know that. The rocky coastline, charming lobster shacks, peaceful lighthouses, and fresh ocean air make it an unforgettable vacation spot.But what's it really like to live in Maine?As a local Realtor who helps people Make Maine Your Home, I've had this conversation with countless clients—many of whom fell in love with Maine during a visit and are now wondering if they should make the leap.Spoiler alert: living in Maine is amazing, but it's a different experience from visiting. Here's what you need to know if you're considering the move.  1. The Pace of Life: Vacationland vs. RealityWhen you're here for a week, it's all about coastal drives, seafood feasts, and soaking in the scenery. But living here means experiencing the rhythm of Maine life—slower, more intentional, and deeply connected to nature.✅ Remote work is on the rise here—Maine had one of the highest rates in the country in 2023.✅ Life is peaceful, but expect longer drives for essentials, especially in rural areas.✅ Winters are no joke—think snow tires, plowing, and prepping for the power to go out!  2. Cost of Living: More Affordable Than You Think?Compared to neighboring states like Massachusetts or New Hampshire, Maine's real estate is surprisingly affordable.

The I Love CVille Show headlines: HUD Median Family Incomes Released Today CVille Area: $125,800 In 2025; $124,200 In 2024 Arlington/Alexandria/DC Area; $163,900 Median Anti-Tesla & Pro-Tesla Protests Saturday At Stonefield How Does UVA Rebuild Its Battered Brand? Charlottesville Business Brokers Has Cash Buyers R Odom Contract: $3.25M Base , 6 Yrs & Bonuses Joel Gardner, Chairman, Jefferson Council, (4/3) Read Viewer & Listener Comments Live On Air The I Love CVille Show airs live Monday – Friday from 12:30 pm – 1:30 pm on The I Love CVille Network. Watch and listen to The I Love CVille Show on Facebook, Instagram, Twitter, LinkedIn, iTunes, Apple Podcast, YouTube, Spotify, Fountain, Amazon Music, Audible, Rumble and iLoveCVille.com.

Home prices are falling fast in some prime real estate markets across the country while others remain stubbornly stuck. What's the defining factor between a stable housing market and one where sellers are actively cutting prices? Housing inventory! This metric defined the 2020 - 2022 run-up in home prices, but the rubber band of demand is snapping back as buyer power grows, housing inventory rises, and investors get even better buying opportunities. Remember when people said, “I'll buy when prices drop”? Well, now might be the time. ResiClub's Lance Lambert joins us to provide a holistic view of housing inventory, prices, demand, and emerging opportunities. Lance walks through the most up-to-date data on where housing inventory is rising fast, where prices are quickly declining, and which markets are holding on as sellers remain in control. We'll also talk about why homebuilding costs are about to JUMP and the reason Warren Buffett sold his homebuilding stocks shortly after buying them. Will construction slow down, limiting new inventory and leading us back into ultra-low supply? If so, this could push home prices higher, creating a prime opportunity for real estate investors. In This Episode We Cover US real estate markets seeing the most and least new inventory, and where prices are falling  Is spiking inventory a worrying sign for the housing market, or are we merely normalizing? What to look at in your housing market to forecast whether prices will rise or fall  Why are homebuilding costs about to JUMP, and could this lead to even more inventory problems? The new housing trend: Older renters, but could this mean more demand for rentals? And So Much More! Links from the Show Join the Future of Real Estate Investing with Fundrise Join BiggerPockets for FREE Sign Up for the On the Market Newsletter Find an Investor-Friendly Agent in Your Area Dave's BiggerPockets Profile ResiClub: The cost breakdown for constructing a single-family home in 2024 ResiClub: Did Warren Buffett see this coming? Homebuilder margins face pressure in 2025 ResiClub: The vanishing young homebuyer: Median first-time homebuyer age jumps from 28 in 1991 to 38 in 2024 Inventory Is Key to a Stable Real Estate Market—Will It Recover? Join Lance's Newsletter Grab Dave's Book, “Real Estate by the Numbers” Jump to topic: (0:00) Intro  (1:27) Hottest and Coldest Markets  (8:00) Should We Be Worried?  (11:00) Where Prices Are Dropping  (14:54) What to Look For In YOUR Market  (17:39) Homebuilding Costs To JUMP  (21:48) Developer Profits Shrink  (24:11) Older Renters, Better for Investors Check out more resources from this show on BiggerPockets.com and https://www.biggerpockets.com/blog/on-the-market-308 Interested in learning more about today's sponsors or becoming a BiggerPockets partner yourself? Email advertise@biggerpockets.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Cancer is one of the most terrifying illnesses of our age - a sudden change that happens silently inside our bodies and slowly eats away at us until there's nothing left. It's also one of the biggest failures of the pharmaceutical age - somewhere between 90 and 97% of all cancer drugs fail at clinical trials. Which is why we're unbelievably excited to bring you our conversation with Dr. Thomas Seyfried, Professor of Biology at Boston College who appears to be hot on the trail of a cure cancer that has nothing to do with the oncology-industrial-complex. According to the dozens of papers he and his colleagues have published over the last few decades, a strict ketogenic diet coupled to a glutamine inhibitor is sufficient to weaken cancer cells to the point that the immune system can actually clear the tumor. A recent paper from his group published in February of 2025 shows the stunning effects of his protocol in a small group of eighteen glioblastoma patients. Median survival for these patients for the last hundred years has been 12-15 months, but with Seyfried's intervention appears to have been extended up to 84 months. That's seven years, for those keeping score.We sit down with Seyfried to take apart his protocol, why it works for cancer, why no one's heard if it, and how everyone has completely misunderstood what cancer actually is.MAKE HISTORY WITH US THIS SUMMER:https://demystifysci.com/demysticon-2025PATREON https://www.patreon.com/c/demystifysciPARADIGM DRIFThttps://demystifysci.com/paradigm-drift-show(00:00) Go!(00:07:33) - Reception of Metabolic Cancer Research(00:10:05) - Breakthrough in Glioblastoma Treatment(00:14:49) - Glutamine-Glutamate Cycle in Cancer(00:16:33) - Challenges and Critiques of Standard Care(00:17:43) - Barriers to Implementing Metabolic Therapies(00:24:19) - Radiation and Cancer Treatment(00:26:07) - Metabolic Approach to Cancer(00:27:30) - Evolutionary Biology's Role in Understanding Cancer(00:28:52) - Mitochondria's Role in Cellular Destiny(00:31:39) - The Oxidative Phosphorylation Process(00:35:28) - Cancer and Mitochondrial Function(00:38:43) - Cellular Electrochemical Gradients(00:41:30) - Cancer's Dependency on Fermentable Fuels(00:45:08) - Glutamine's Role in Cancer Treatment(00:52:11) - Patient Compliance and Dietary Challenges(00:55:33) - Glucose Ketone Index for Health Monitoring(01:06:48) - Fenbendazole and Cancer Research(01:10:02) - Medical Industry Business Models(01:13:27) - Diets and Nutritional Ketosis(01:17:06) - Metabolic Variability and Personalization(01:19:25) - Exercise and Metabolic Health(01:23:43) - Historical Misconceptions in Cancer Treatment(01:26:21) - Obesity and Cancer Prevention(01:28:00) - Metabolic Theories of Cancer(01:47:18) - Metastatic Cancer Origins(01:55:24) - Therapeutic and Collaborative Approaches(01:59:57) - Practical Steps and Transformations#CancerResearch, #glioblastoma, #CancerAwareness, #Oncology, #CancerTreatment, #CancerSurvivor, #FightCancer, #EndCancer, #CancerSupport, #ClinicalTrials, #CancerWarrior, #BeatCancer, #CureCancer, #CancerFighter, #StayStrong, #CancerCommunity, #philosophypodcast, #sciencepodcast, #longformpodcast ABOUS US: Anastasia completed her PhD studying bioelectricity at Columbia University. When not talking to brilliant people or making movies, she spends her time painting, reading, and guiding backcountry excursions. Shilo also did his PhD at Columbia studying the elastic properties of molecular water. When he's not in the film studio, he's exploring sound in music. They are both freelance professors at various universities. SOCIAL: - Discord: https://discord.gg/MJzKT8CQub- Facebook: https://www.facebook.com/groups/DemystifySci- Instagram: https://www.instagram.com/DemystifySci/- Twitter: https://twitter.com/DemystifySciMUSIC: -Shilo Delay: https://g.co/kgs/oty671

Home prices are falling fast in some prime real estate markets across the country while others remain stubbornly stuck. What's the defining factor between a stable housing market and one where sellers are actively cutting prices? Housing inventory! This metric defined the 2020 - 2022 run-up in home prices, but the rubber band of demand is snapping back as buyer power grows, housing inventory rises, and investors get even better buying opportunities. Remember when people said, “I'll buy when prices drop”? Well, now might be the time. ResiClub's Lance Lambert joins us to provide a holistic view of housing inventory, prices, demand, and emerging opportunities. Lance walks through the most up-to-date data on where housing inventory is rising fast, where prices are quickly declining, and which markets are holding on as sellers remain in control. We'll also talk about why homebuilding costs are about to JUMP and the reason Warren Buffett sold his homebuilding stocks shortly after buying them. Will construction slow down, limiting new inventory and leading us back into ultra-low supply? If so, this could push home prices higher, creating a prime opportunity for real estate investors. In This Episode We Cover: Is spiking inventory a worrying sign for the housing market, or are we merely normalizing? What to look at in your housing market to forecast whether prices will rise or fall  Why are homebuilding costs about to JUMP, and could this lead to even more inventory problems? The new housing trend: Older renters, but could this mean more demand for rentals? And So Much More! Links from the Show Join BiggerPockets for FREE Let Us Know What You Thought of the Show! Ask Your Question on the BiggerPockets Forums BiggerPockets YouTube Apply to Be a BiggerPockets Real Estate Guest ResiClub: The cost breakdown for constructing a single-family home in 2024 ResiClub: Did Warren Buffett see this coming? Homebuilder margins face pressure in 2025 ResiClub: The vanishing young homebuyer: Median first-time homebuyer age jumps from 28 in 1991 to 38 in 2024 Invest in Private Market Real Estate with the Fundrise Flagship Fund Grab Dave's Book, “Real Estate by the Numbers” Sign Up for the BiggerPockets Real Estate Newsletter Find an Investor-Friendly Agent in Your Area Inventory Is Key to a Stable Real Estate Market—Will It Recover? Join Lance's Newsletter Connect with Dave Check out more resources from this show on BiggerPockets.com and https://www.biggerpockets.com/blog/real-estate-1101 Interested in learning more about today's sponsors or becoming a BiggerPockets partner yourself? Email advertise@biggerpockets.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

(2:09) Sote-säästöt julkaistiin lopulta — mikä vaikutus? (17:48) Demarien linja, perusteltua vai oma maali? (24:36) EVA:n mielipidekysely suomalaisista medioista (30:16) Parhaat ryhmäviestit

The Bureau of Labor Statistics released data on the median salaries of Americans, revealing a significant gap between what people earn and what they feel is necessary to live comfortably. In this episode, Art shares his thoughts on the findings and offers tips for cultivating a content heart.Resources: 8 Money MilestonesAsk a Money Question!

In this episode of the Primal Potential Podcast, we're diving into three powerful but simple strategies to help you optimize your blood sugar, improve your insulin sensitivity, and increase your energy levels. These are real-world, easy-to-implement hacks that go beyond the usual “eat less sugar” advice. Before we get started, grab your copy of my new Fat Loss E-Book! Here's the link. And, head over to my new YouTube channel to subscribe and turn on notifications before the new Carb Series kicks off next week.  Hack #1: Get Sunlight First Thing in the Morning ☀️ Did you know that getting direct sunlight within the first hour of waking helps reset your circadian rhythm, which plays a major role in blood sugar regulation and insulin sensitivity? Pairing this with light movement (like a 10-minute walk or some gentle stretching) can improve how efficiently your body uses glucose before breakfast. What the Science Says: On average, exposure to sunlight improved insulin sensitivity by 18.75%. Median improvement was 18%, meaning half of people experienced even greater benefits. Range of effects: Sunlight exposure improved insulin function by 15-22%. Glucose tolerance: Participants who got more sunlight saw a 12-16% improvement in how well their bodies processed carbohydrates.

Today, as part of our “Tricks of the Trade” series, we’re at the Houston Livestock Show and Rodeo, where students put goats and lambs up for sale to the highest bidder. Here, livestock auctions generate a pile of philanthropic money for a Texas scholarship fund, and the bids go up and up and up. But first: Air travel is in a snarl today with a power outage at London’s Heathrow Airport.

Today, as part of our “Tricks of the Trade” series, we’re at the Houston Livestock Show and Rodeo, where students put goats and lambs up for sale to the highest bidder. Here, livestock auctions generate a pile of philanthropic money for a Texas scholarship fund, and the bids go up and up and up. But first: Air travel is in a snarl today with a power outage at London’s Heathrow Airport.

How do local Indianapolis Real Estate Investors compete in an increasingly competitive market? The Home Value growth in Indianapolis is 42% since 2020. The Median home price in 2020 was$170,000, but it has increased to $240,000. 2%-4% mortgage rates have risen to 8%.Many people are leaving bigger cities for more affordable living in Indiana. Large Out-of-State corporate investors are swooping in to grab up single-family homes and apartments. Competition for finding good real estate deals is increasingly hard to come by. It's like a gold rush in Indiana.But there is hope for success in Indy for wholesalers and other local investors. Partly, it does take a bit of extra work digging twice as hard as we've been used to. Some of us have gotten lazy, taking the easy deals for granted. But there are deals out there.Local investors and wholesalers have a lot of advantages compared to out-of-state buyers. Many out of state buyers have been developing bad reputations. This is where local investors with consistent track records and face to face encounters goes a long way.Out of State buyers may be able to offer more money, and sometimes that's what it comes down to. But local buyers can offer trust, as many sellers are getting burned by corporate conglomerates. And many out of state investors are coming for 6-12 months and then packing up and leaving. For those local buyers sticking around, consistency builds your credibility.It's not about making big adjustments for buyers right now. It's about make small ones. Maybe you can safely buy at a little higher ARV percentage than you used to be able. Maybe you need to attend more Meet-Ups and other events to make a few extra connections that get you that deal. Maybe you just need to have your ducks lined up better for financing to be a little bit quicker to get the deal when available, so you can close faster. Maybe it's exploring new areas that will be the next Fountain Square. Maybe doing delayed flips and continuing to rent for a few years is a successful recipe as properties appreciate.The moral of the story is, those investors who are in the Indianapolis area for the long-term are the ones who will eventually win out in the end. In the mean time, listen to Brett & Ronnie discuss some tips and tactics that could help you in your short game at this season of the real estate market.

Send us a textJim dives into the latest National Association of Realtors Profile of Homebuyers and Sellers, revealing critical data points to help real estate professionals target their marketing efforts more effectively. Highlights From the Profile of Home Buyers and Sellers The demographic trends show significant shifts in buyer age and preferences that create new opportunities for agents who understand these changes.• First-time buyer share decreased to 24% of market, lowest since NAR began collecting data in 1981• Median first-time buyer age increased to 38 years, repeat buyer age rose to 61 years• 86% of all buyers utilized a real estate agent• 77% of buyers interviewed only one agent before deciding• 40% of buyers found their agent through a friend, neighbor, or relative• Online photos (41%) were rated as the most valuable content when searching for homes• Typical home seller age reached 63 years, with median ownership of 10 years• FSBOs sold for $55,000 less on average than agent-represented homes• Modern kitchens with islands (60%), home offices, and energy efficiency features are high priorities• Millennials (25-43) represent the largest buying group at 38% of purchasesFor questions about home inspections or to learn how Habitation Investigation helps real estate agents close more deals, call us or visit homeinspectionsinohio.com.Support the showTo learn more about Habitation Investigation, the Two-time Winner of the Best Home Inspection Company in the Midwest Plus the Winner of Consumer Choice Award for Columbus Ohio visit Home Inspection Columbus Ohio - Habitation Investigation (homeinspectionsinohio.com) Continuing Education for Ohio Agents Scheduled classes Continuing Education for Ohio Agents Course listingsFacebook Page FacebookFor home buyers: What to expect from a home inspection. YT video for home buyersHome Buyer and Seller Resources | Habitation Investigation Heartland Commercial Property InspectionsIf you would like to be a guest on the podcast contact us and let us know. You can visit Home (jimtroth.com) and go to the podcast page or message Habitation Investigation.

We are in a NEUTRAL MARKET! Median sold price in Leon county is $302000 - 3% more than 2024We are in a normal market!

Five Questions To Ask Before Moving To Maine | Living in Maine Thinking About Moving to Maine? Ask Yourself These 10 Questions First!

Ben and Nathan reassure a listener that an above median LSAT can carry your application, even with a less than stellar GPA. Read more on our website. Email daily@lsatdemon.com with questions or comments. Watch this episode on Youtube!

This week, we talk about median playtime, weapon balance, and revisiting our older games. From chaotic co-op antics to echolocation-based platforming, our game jam experiments were always a blast, even if they were never quite commercially viable. But hey, you make some games for players and some just for the joy of making them.Support Crashlands 2!Official Website: https://www.bscotch.net/games/crashlands-2/Trailer: https://www.youtube.com/watch?v=ib7fzLf59voSteam Wishlist: https://store.steampowered.com/app/1401730/Crashlands2/Google Play:https://play.google.com/store/apps/details?id=com.bscotch.crashlands2Apple: https://apps.apple.com/us/app/crashlands-2/id152819933100:32 Intro00:50 Thanks to our supporters! (https://moneygrab.bscotch.net)01:04 Crashlands 2 Beta18:29 Marketing24:22 Balancing weapons33:28 Giantmuskrat: Would you replay your older titles on https://bscotch.itch.io/ and give them a score on the nailed it/whiffed it scale?To stay up to date with all of our buttery goodness subscribe to the podcast on Apple podcasts (apple.co/1LxNEnk) or wherever you get your audio goodness. If you want to get more involved in the Butterscotch community, hop into our DISCORD server at discord.gg/bscotch and say hello! Submit questions at https://www.bscotch.net/podcast, disclose all of your secrets to podcast@bscotch.net, and send letters, gifts, and tasty treats to https://bit.ly/bscotchmailbox. Finally, if you'd like to support the show and buy some coffee FOR Butterscotch, head over to https://moneygrab.bscotch.net. ★ Support this podcast ★

Brad Hutchings returns to discuss AI. Pete A Turner of the Break It Down Show has been working to use AI in some of his projects. He tried to find the Median debut for all baseball players. He did the work to find Detroit Tiger phenom, Jim Proctor who today is the middle player in all players, based on debut date, in MLB history (per baseball reference). Pete Writes about Jim in an article on X. Brad and Pete discuss Grok's inability to find the median player. Pete tried a few other AIs...they just don't work this way. Brad notes that AIs will give loquacious answers, but the results are more fantasy than fact. Then a funny test happens...what happens when you ask an AI, while offline, to reference an online resource...well...AI does a performance of giving an answer. This is a fun one.

In this JCO Article Insights episode, Peter Li summarizes “Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years,” by Dr. Jianwei Zhang et al. published on December 13, 2024. TRANSCRIPT Peter Li: Hello and welcome to the JCO Article Insights. I'm your host Peter Li and today we will be discussing the Journal of Clinical Oncology article, “Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years,” by Dr. Jianwei Zhang et al.  For a reminder to the audience, the FOWARC study is a Chinese-based study that looked into the treatment of locally advanced rectal cancers with neoadjuvant chemotherapy based regimens with or without radiation. This study was first published back in 2019 where the three-year data showed no difference in three-year disease-free survival over survival between the three study arms. As a reminder of what those arms were, there were one historical control and two interventional arms. The control arm used 5-FU with radiation therapy with five cycles of 5-fluorouracil with radiation during cycles two to four followed by surgery and then seven cycles adjuvantly. Their first interventional arm was the same as the control arm with the addition of oxaliplatin on day 1of each cycle. And lastly, the third arm was FOLFOX only for four to six cycles followed by surgery and then six to eight cycles adjuvantly completing about a total of 12 weeks of chemotherapy.  They recruited about 495 patients with 165 patients randomized to each arm. They were relatively well balanced by age, clinical staging and distance from the anal verge. Median age was about mid-50s with a slight male predominance and patients were primarily stage 3 with 20% to 30% being stage 2. About 30% had clinical T4 disease and about 25% had clinical N2 disease. Median follow up time was 122.5 months or 10 years and their follow up endpoints were disease-free survival, overall survival and local recurrence, and they also performed subgroup analyses based on post surgical pathological staging. Survival was analyzed using Kaplan-Meier method with a significant threshold of p being less than 0.05. About 451 patients actually underwent surgery, which is about 91% of patients. The main reason for not going through surgery was due to refusal but one was due to toxicity and two were due to disease progression in the control arm. Follow up loss rate was about 10% in each group. Now looking at their primary endpoints in their initial study, local recurrence was about 8.8% in the control arm versus 7.9% in the FOLFOX radiation group versus 9.2% in the FOLFOX only group. Distant metastasis was about 30% in each arm and the sites of metastases were primarily in the lung and liver.   Now, following up with 10 years, there were only three new events in the chemoradiation group with local recurrence happening at 10.8% in the control arm versus 8% in the FOLFOX RT group versus 9.6% in the chemo only group. These findings were not statistically significant. In their subgroup analysis by pathological staging, they found that pathological CR or complete response had a lower rate of local recurrence compared to those with increasing pathological staging coming in at 3% versus 4.3% versus 11.6% versus 15.8% in pCR versus Stage 1, 2, 3 respectively. And they found no difference in each stage with each interventional arm. Looking at long term survival their 10-year disease free survival showed 52.5% in the 5-FU radiation group versus 62.6% in the FOLFOX RT group versus 60.5% in the chemotherapy only group with no statistically significant difference between three groups. By pathological staging, they found improved 10-year disease survival in those who achieved pathological complete response versus those who did not with 84.3% in the pCR group versus 78.7% versus 56.8% versus 27.7% in the stage 1 versus 2 versus 3 group. And again they found no statistical significance difference between each arm.   Now looking at the 10-year overall survival rates between the three arms, in the control arm the 10-year overall survival was 65.9% versus 72.3% in the FOLFOX RT group versus 73.4% in the chemo only group. By pathological stage, again, they showed a statistically significant difference in those who achieved pCR versus those who had pathological stage 1 to 3 disease with overall survival being 92.4% in those who achieved pCR versus 84.9% versus 68.6% versus 48.8% in stage 1, 2, 3 respectively. Now in the discussion, authors mentioned that with a median follow up of 10 years, FOLFOX alone had similar disease-free survival, local recurrence and distant metastasis and overall survival compared to those who received neoadjuvant chemoradiation, justifying the omission of radiation without compromising results or outcomes for each patient. There were no differences in subgroup analysis for disease free survival local recurrence or overall survival based on pathological staging. There were only three new events compared to the last follow up, with local recurrence happening only in the chemo radiation groups. Local recurrence rates at 10 years was about 10%. Compared to other clinical trials such as CAO, ARO or AIO-94, the rate of local recurrence was similar to those historical trials.  The authors also compared their findings to the PROSPECT study which looks at the use of total neoadjuvant chemo radiation versus chemotherapy alone, which boasted only about a 2% local recurrence rate. But as a reminder, high risk locally advanced rectal cancers were excluded, mainly those with T4 or N2 disease, which may explain the difference in terms of local recurrence in the PROSPECT versus this study. Another finding is that pathological complete responses are also an important prognostic marker with lower 10-year local recurrence rate, disease-free survival and overall survival with worse outcomes with increased pathological staging. Distant metastasis rates were still at 30%, with the most common site being lung then liver then lymph nodes consistent with other historical studies. Chemotherapy seemed to be better at reducing liver mets than lung metastasis per their findings. In their post hoc analysis of their own study, chemo radiation was also associated with higher incidence of low anterior resection syndrome and persistent ostomy compared to chemotherapy alone, meaning that they had better quality of life with the chemotherapy only approach.  In conclusion, a chemotherapy only approach can be safe and a feasible treatment for locally advanced rectal cancer without compromising outcomes. Omission of radiation may reduce the risk of overtreatment and improve quality of life for some of these patients. However, this does not necessarily exclude the role of radiation as it may still play a role in a response escalation approach for those who do not respond to chemotherapy alone.   This wraps up today's episode. Thank you for listening to JCO Article Insights. Please come back for more interviews and article summaries and be sure to leave us a rating and review so others can find our show. For more podcasts and episodes from ASCO, please visit asco.org/podcasts.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.  

New data provided to RNZ by Corelogic shows just how much house prices have shot up since the turn of the century. In some parts of the country, the median price has increased 1000 percent over 25 years. Money correspondent Susan Edmunds spoke to Lisa Owen.

Jay and Ryan discuss what you should be doing to build your business this year and what should you NOT be doing, inflation comes in higher than expected, the median age of a renter skyrockets, and YouTube users are watching on their TV's now more than ever before.

Welcome to the "Saturday Morning Golf Stat" from the Hack it Out Golf Podcast. Today's episode brings us to new territory, as the TOUR's allows for more granular stats: how does green firmness affect how close a Tour pro can get to the pin? In this episode, Mark and Greg guess the median proximity for soft, medium, and hard greens. Lou brings the answer—and it will likely surprise you. How much difference do you think it makes? The guys then give a short discussion about how to make changes to your game to adjust to conditions so that you can shoot your best scores. Each of these will be a mini-episode (10-15 minutes long) about an interesting golf stat. We will discuss what you can learn, and most importantly, how you can apply this on the golf course to lower your scores and lower your handicap. Listen on your drive to the golf course or over your Saturday morning coffee! Data is sourced from Arccos Golf. They have over 1 BILLION shots in their database.  Check them out at: https://www.arccosgolf.com/  Use code MARK15 for 15% off! Learn more about your ad choices. Visit megaphone.fm/adchoices

Introduction (Bruce Almighty movie clip) It is possible that you are here today and are wondering how and why it is that a good God would allow some of the hard things you were forced to experience so far. Maybe you have said or identify with Bruces description of his own experience with God: God is a mean kid sitting on an anthill with a magnifying glass, and I'm the ant. He could fix my life in five minutes if He wanted to, buthe'd rather burn off my feelers and watch me squirm. If God is good, and if he is infinitely and perfectly sovereign how and why does He allow so much suffering in the world? How is it that He allows so much evil when he is the measure of all that is holy and good? There seems to be a great divide between the God we read about in our Bibles and the world we live in. What are we supposed to do with the confusion, disappointment, anger, evil, and suffering God has allowed into our lives? Is it okay to be angry with God when we suffer? I plan to answer the above questions, but we must start with the nature and character of God as He revealed Himself to Moses after 40 years in the desert as a fugitive of Egypt after he murdered one of Pharoahs guards. Moses Encounter with a Holy God Here is what you need to know about what led up to Moses experience with the burning bush. God made a promise to Abraham, Isaac, and then to Jacob that their children would become His people; the promise was threefold and included the promise of land, the increase of their people, and that their people would eventually be a blessing to the nations. However, God also promised that they would spend years in a land where they would be afflicted (see Gen. 15:13; Exod. 12:40-41). When Moses was born, the Hebrew people had spent centuries living in Egypt. The Hebrew people were first welcomed as honored guests under Joseph (one of the sons of Jacob) who was second to Pharaoh, but as the years past, so did the memory of Joseph. The Hebrews eventually became the slaves of another Pharaoh; he was so threatened by the birth rate of the Hebrews, that he implemented infanticide as the law of the land and wrote into law that every Hebrew son born was to be thrown into the Nile. Moses mother refused to murder her baby, so she kept his birth a secret until she could not do so any longer; she put baby Moses in a basket covered with tar and pitch, put him in it, and floated it down the Nile where Pharaohs daughter eventually found the basket with baby Moses whom she raised as her own. Moses grew up in Pharaohs house, but he was also aware of his roots as a Hebrew man. We know that Moses had a temper, and on two occasions, it cost him much. On one such occasion, after seeing an Egyptian beating a Hebrew, Moses killed the Egyptian and buried his body in the sand (see Exod. 2:11-12). When Moses learned that others knew that he killed the Egyptian, he fled and hid in the land of Midian. Moses spent the next 40 years of his life in Median, got married, and worked for his father-in-law Jethro. What We Learn About God Through Moses Encounter Before we can answer where or not it is okay to be angry with God, we need to consider the God who found Moses in Midian; against the backdrop of Josephs 13 years of suffering, the generations of slavery the Hebrews suffered in Egypt, and Moses 40 years in Midian. God is Holy: He is not like us. Moses approached the burning bush not only because it was weird, but because God called to him, from the midst of the bush and said, Moses! Moses! Moses response was simple: Here I am. Notice that as Moses got closer to the burning bush, God said to him, Do not come near here; remove your sandals from your feet, for the place on which you are standing is holy ground. What made the ground holy? The presence of God made it holy. As R.C. Sproul wrote in his timeless and classic book, The Holiness of God: God alone is holy in Himself. Only God can sanctify something else. Only God can give the touch that changes it from the commonplace to something special, different, and apart.[1] Now, just so that you are aware, it is not only Moses, a mere mortal human, who must remove his sandals in the presence of holiness. The seraphim whose sole purpose is worship above the throne of God are not exempt from the kind of respect and reverence that was expected of Moses in the presence of the Holy One. Isaiah was invited into the throne room of Almighty God, and this is what he saw: In the year of King Uzziahs death I saw the Lord sitting on a throne, lofty and exalted, with the train of His robe filling the temple. Seraphim were standing above Him, each having six wings: with two each covered his face, and with two each covered his feet, and with two each flew. And one called out to another and said, Holy, Holy, Holy, is the Lord of armies. The whole earth is full of His glory. And the foundations of the thresholds trembled at the voice of him who called out, while the temple was filling with smoke. (Isa. 6:14) The great Seraphim must cover their face and their feet in the presence of a Holy God even though they have not been stained by sin, but because they, like us, are creatures and God is the Creator. Isaiahs response before the Holy One was appropriate: Woe to me, for I am ruined! Moses response was not only to remove his sandals, but to hide his face, for he was afraid to look at God (v. 6). Why? Because God is holy, and we are not. God is not like us. God is Omniscient: He sees the big picture. When we come to verse 6, God let Moses who it was that was speaking to him: I am the God of your fatherthe God of Abraham, the God of Isaac, and the God of Jacob. And just as God was intimately acquainted with the lives of Moses forefathers, He was aware of the suffering of Moses kinsmen in Egypt: I have certainly seen the oppression of My people who are in Egypt, and have heard their outcry because of their taskmasters, for I am aware of their sufferings (v. 7). When the Hebrews entered into Egypt, they were the size of a small clan, but after hundreds of years in Egypt, they had become the size of a small nation. When Moses fled to Midian, he was a 40-year-old used to royalty; the Moses who stood before the burning bush was any eighty-year-old shepherd. What the Hebrews did not understand, and what Moses could not have fathomed was that God was using the ugly, the hard, and the pain for something far greater than they could have imagined. God was aware of their suffering all along, and now in that moment was the right time to, rescue them from the power of the Egyptians, and to bring them up from the land to a good and spacious land, to a land flowing with milk and honey... (v. 8) just as He promised Abraham, Isaac, and Jacob centuries before. So, God said to Moses: And now come, and I will send you to Pharaoh, so that you may bring My people, the sons of Israel, out of Egypt (v. 10). To which, Moses appropriately responded: Who am I, that I should go to Pharaoh, and that I should bring the sons of Israel out of Egypt? All that the Hebrews could see was their slavery and suffering; all that Moses could see was his failures and incompetence. What God saw was that He alone can use the foolish to shame the wise and the weak to shame the strong (see 1 Cor. 1:26-31). What God saw was that His timing was infinitely better because He saw the big picture. God is Faithful: He keeps His promises. Remember that the Hebrew slaves in Egypt were surrounded by an Egyptian culture that worshiped Egyptian gods who were not gods, but demons (see Deut. 32:17). Moses questioned what name he was to give to the Hebrew slaves if they were to ask Who it was that sent Moses to deliver them (v. 13). Here is Gods answer: And God said to Moses, I AM WHO I AM; and He said, This is what you shall say to the sons of Israel: I AM has sent me to you (v. 14). Then God continued: This is what you shall say to the sons of Israel: Yahweh, the God of your fathers, the God of Abraham, the God of Isaac, and the God of Jacob, has sent me to you. This is My name forever, and this is the name for all generations to use to call upon Me (v. 15). In other words, God told Moses: You tell them that Yahweh sent you! At the heart of Gods answer are four facts about His nature for why the Israelites should believe the He could and would deliver them: Yahweh is self-existent and not dependent. God was unlike the Egyptian gods who were created by their own culture. Yahweh is the Elohim over elohims. The great I AM was bigger than the plight of the Israelites as He is greater than any trouble in our own lives. Yahweh is creator and sustainer. Who wrote the Law of Thermodynamics? Who governs the laws of gravity?Who grants the Sun permission to get up in the morning? Who gave the song for the birds to sing? Who owns the cattle on a thousand hills? Who brings men into power, raises nations into prominence and then brings them to naught? Is it not the great I AM who keeps His covenant promises. Yahweh is unchanging. Yahweh is the great I AM whose personality does not change. He does not suffer from a multi-personality disorder. He does not change with the ideas of his devotees. He is unmovable because He does not change. Because Yahweh is unchanging, He is constant unlike the gods of the Egyptians or whatever idol we may have set up in our own heart. Yahweh is eternal. Because He is the great I AM, Yahweh will never have a beginning nor will he ever have an end. Even though the fool has said there is no God, Yahweh is absolute reality with nothing before or after Him. The great I AM does not sleep, slumber, slack off, or slip into a daydream stupor. What God told Moses is this: Moses, you tell My people that the Covenant Keeper who promised their forefathers that He would make them into a great nation, would give them land as a nation, and would make them a blessing to the nations... you tell them the Faithful and Living One sent you! God keeps His promises because He alone is faithful even when we are not. Conclusion So, the question you may still be asking is whether it is or is not okay to be angry with God? Is it okay to be angry with He who is Holy and infinitely unlike us creatures? Is it okay to be angry with the One who sees and knows all things perfectly? Is it okay to be angry with the One who keeps His covenant promises because He is faithful while we are faithless time and time again? Is it okay to be angry with Yahweh who is Almighty God? As you know, God did use Moses to lead the Hebrews out of the bondage of slavery from Egypt, and He did it miraculously and profoundly. Yet, even after God delivered them, Moses found himself shepherding and leading a people who demonstrated over and over again just how faithless they really were. After their grievous sin of idolatry with the golden calf, Moses pleaded with God for mercy for His people who sinned, and God granted it. In Exodus 33:17-34:9 we are given a glimpse into Moses heart as a shepherd absolutely in love with Yahweh, and in that exchange asked to see God. God told Moses that he could not see His face and live, but this is what God did say He would do: I Myself will make all My goodness pass before you, and will proclaim the name of the Lord before you; and I will be gracious to whom I will be gracious, and will show compassion to whom I will show compassion (Exod. 33:19). When God did pass, He hid Moses in the cleft of a rock, and allowed His goodness to pass by him and when it did, Moses heard God proclaim of His goodness: The Lord, the Lord God, compassionate and merciful, slow to anger, and abounding in faithfulness and truth; who keeps faithfulness for thousands, who forgives wrongdoing, violation of His Law, and sin; yet He will by no means leave the guilty unpunished, inflicting the punishment of fathers on the children and on the grandchildren to the third and fourth generations (Exod. 34:67). So, what does Gods goodness include? It includes His mercy, patience, faithfulness, truth, and grace. But it also includes His justice and wrath in response to sin. So, again I ask you: Is it okay to be angry with the God who is Holy and infinitely unlike us creatures? Is it okay to be angry with the God who sees and knows all things perfectly? Is it okay to be angry with a holy God who is faithful while we are faithless time and time again? Is it okay to be angry with Yahweh who is Almighty God? Let me reframe the question for you: If God is infinitely good and we are the ones who need to improve upon being good, do we have any right to be angry with God? Now, think about the effects anger has on a relationship. When you are angry with someone because you believe you have been wronged by that person, it interferes with communication. Anger towards a friend or a member of your family often drives a wedge between you and that person. Anger typically results in the one offended distancing himself/herself from the person who wronged them. If there is no need for God to improve, especially in being good, then to suggest that it is okay to be angry with Him is to suggest that it is okay to accuse Him of wrongdoing. Psalm 145 is a great Psalm to visit while suffering or confused why God would allow you to suffer; verses 8-9 say the following: The Lord is gracious and compassionate; slow to anger and great in mercy. The Lord is good to all, and His mercies are over all His works. Again in Psalm 145:17-18, The Lord is righteous in all His ways, and kind in all His works. The Lord is near to all who call on Him, to all who call on Him in truth. I have head Christians and Pastors console the suffering and confused: It is okay to be angry with God. To which I ask, How is it okay to be angry with He who is infinitely holy, how is it okay to be angry with Him who sees all while my vision is limited, how is it okay to be angry with the Almighty whose faithfulness has been proven time and time again while my faithfulness has been found wanting more than I count? Listen dear friend, not only are we not given permission in all of Scripture to be angry with God, but we also have no right to be angry with Him. Here is what is permitted and even expected by God: We can be confused, frustrated, and even hurt emotionally. If God is infinitely good, which He is, then we can run to Him with our confusion, we can run to Him with our frustration, and we can run to Him with our wounded and bleeding hearts knowing that even though we cant see His goodness in and through our pain, we can trust that He is still good and will turn it around in His way and in His time for His glory and our good! After Moses experienced the goodness of God when His glory passed by while he was in the cleft of the rock, Moses responded on behalf of the sins of Israel: If in any way I have found favor in Your sight, Lord, please may the Lord go along in our midst, even though the people are so obstinate, and pardon our wrongdoing and our sin, and take us as Your own possession (Exod. 34:9). Dear brothers and sisters, if your faith and trust is in Jesus as proof of Gods infinite goodness, then my plea to you is not to run from Him in anger but to him with all your pain, confusion, and frustration. Run to the God of Romans 8:28-32, And we know that God causes all things to work together for good to those who love God, to those who are called according to His purpose. For those whom He foreknew, He also predestined to become conformed to the image of His Son, so that He would be the firstborn among many brothers and sisters; and these whom He predestined, He also called; and these whom He called, He also justified; and these whom He justified, He also glorified. What then shall we say to these things? If God is for us, who is against us? He who did not spare His own Son, but delivered Him over for us all, how will He not also with Him freely give us all things? [1] Sproul, R.C., The Holiness of God (Wheaton, IL: Tyndale House Publishers; 1998), 39.

Introduction (Bruce Almighty movie clip) It is possible that you are here today and are wondering how and why it is that a good God would allow some of the hard things you were forced to experience so far. Maybe you have said or identify with Bruces description of his own experience with God: God is a mean kid sitting on an anthill with a magnifying glass, and I'm the ant. He could fix my life in five minutes if He wanted to, buthe'd rather burn off my feelers and watch me squirm. If God is good, and if he is infinitely and perfectly sovereign how and why does He allow so much suffering in the world? How is it that He allows so much evil when he is the measure of all that is holy and good? There seems to be a great divide between the God we read about in our Bibles and the world we live in. What are we supposed to do with the confusion, disappointment, anger, evil, and suffering God has allowed into our lives? Is it okay to be angry with God when we suffer? I plan to answer the above questions, but we must start with the nature and character of God as He revealed Himself to Moses after 40 years in the desert as a fugitive of Egypt after he murdered one of Pharoahs guards. Moses Encounter with a Holy God Here is what you need to know about what led up to Moses experience with the burning bush. God made a promise to Abraham, Isaac, and then to Jacob that their children would become His people; the promise was threefold and included the promise of land, the increase of their people, and that their people would eventually be a blessing to the nations. However, God also promised that they would spend years in a land where they would be afflicted (see Gen. 15:13; Exod. 12:40-41). When Moses was born, the Hebrew people had spent centuries living in Egypt. The Hebrew people were first welcomed as honored guests under Joseph (one of the sons of Jacob) who was second to Pharaoh, but as the years past, so did the memory of Joseph. The Hebrews eventually became the slaves of another Pharaoh; he was so threatened by the birth rate of the Hebrews, that he implemented infanticide as the law of the land and wrote into law that every Hebrew son born was to be thrown into the Nile. Moses mother refused to murder her baby, so she kept his birth a secret until she could not do so any longer; she put baby Moses in a basket covered with tar and pitch, put him in it, and floated it down the Nile where Pharaohs daughter eventually found the basket with baby Moses whom she raised as her own. Moses grew up in Pharaohs house, but he was also aware of his roots as a Hebrew man. We know that Moses had a temper, and on two occasions, it cost him much. On one such occasion, after seeing an Egyptian beating a Hebrew, Moses killed the Egyptian and buried his body in the sand (see Exod. 2:11-12). When Moses learned that others knew that he killed the Egyptian, he fled and hid in the land of Midian. Moses spent the next 40 years of his life in Median, got married, and worked for his father-in-law Jethro. What We Learn About God Through Moses Encounter Before we can answer where or not it is okay to be angry with God, we need to consider the God who found Moses in Midian; against the backdrop of Josephs 13 years of suffering, the generations of slavery the Hebrews suffered in Egypt, and Moses 40 years in Midian. God is Holy: He is not like us. Moses approached the burning bush not only because it was weird, but because God called to him, from the midst of the bush and said, Moses! Moses! Moses response was simple: Here I am. Notice that as Moses got closer to the burning bush, God said to him, Do not come near here; remove your sandals from your feet, for the place on which you are standing is holy ground. What made the ground holy? The presence of God made it holy. As R.C. Sproul wrote in his timeless and classic book, The Holiness of God: God alone is holy in Himself. Only God can sanctify something else. Only God can give the touch that changes it from the commonplace to something special, different, and apart.[1] Now, just so that you are aware, it is not only Moses, a mere mortal human, who must remove his sandals in the presence of holiness. The seraphim whose sole purpose is worship above the throne of God are not exempt from the kind of respect and reverence that was expected of Moses in the presence of the Holy One. Isaiah was invited into the throne room of Almighty God, and this is what he saw: In the year of King Uzziahs death I saw the Lord sitting on a throne, lofty and exalted, with the train of His robe filling the temple. Seraphim were standing above Him, each having six wings: with two each covered his face, and with two each covered his feet, and with two each flew. And one called out to another and said, Holy, Holy, Holy, is the Lord of armies. The whole earth is full of His glory. And the foundations of the thresholds trembled at the voice of him who called out, while the temple was filling with smoke. (Isa. 6:14) The great Seraphim must cover their face and their feet in the presence of a Holy God even though they have not been stained by sin, but because they, like us, are creatures and God is the Creator. Isaiahs response before the Holy One was appropriate: Woe to me, for I am ruined! Moses response was not only to remove his sandals, but to hide his face, for he was afraid to look at God (v. 6). Why? Because God is holy, and we are not. God is not like us. God is Omniscient: He sees the big picture. When we come to verse 6, God let Moses who it was that was speaking to him: I am the God of your fatherthe God of Abraham, the God of Isaac, and the God of Jacob. And just as God was intimately acquainted with the lives of Moses forefathers, He was aware of the suffering of Moses kinsmen in Egypt: I have certainly seen the oppression of My people who are in Egypt, and have heard their outcry because of their taskmasters, for I am aware of their sufferings (v. 7). When the Hebrews entered into Egypt, they were the size of a small clan, but after hundreds of years in Egypt, they had become the size of a small nation. When Moses fled to Midian, he was a 40-year-old used to royalty; the Moses who stood before the burning bush was any eighty-year-old shepherd. What the Hebrews did not understand, and what Moses could not have fathomed was that God was using the ugly, the hard, and the pain for something far greater than they could have imagined. God was aware of their suffering all along, and now in that moment was the right time to, rescue them from the power of the Egyptians, and to bring them up from the land to a good and spacious land, to a land flowing with milk and honey... (v. 8) just as He promised Abraham, Isaac, and Jacob centuries before. So, God said to Moses: And now come, and I will send you to Pharaoh, so that you may bring My people, the sons of Israel, out of Egypt (v. 10). To which, Moses appropriately responded: Who am I, that I should go to Pharaoh, and that I should bring the sons of Israel out of Egypt? All that the Hebrews could see was their slavery and suffering; all that Moses could see was his failures and incompetence. What God saw was that He alone can use the foolish to shame the wise and the weak to shame the strong (see 1 Cor. 1:26-31). What God saw was that His timing was infinitely better because He saw the big picture. God is Faithful: He keeps His promises. Remember that the Hebrew slaves in Egypt were surrounded by an Egyptian culture that worshiped Egyptian gods who were not gods, but demons (see Deut. 32:17). Moses questioned what name he was to give to the Hebrew slaves if they were to ask Who it was that sent Moses to deliver them (v. 13). Here is Gods answer: And God said to Moses, I AM WHO I AM; and He said, This is what you shall say to the sons of Israel: I AM has sent me to you (v. 14). Then God continued: This is what you shall say to the sons of Israel: Yahweh, the God of your fathers, the God of Abraham, the God of Isaac, and the God of Jacob, has sent me to you. This is My name forever, and this is the name for all generations to use to call upon Me (v. 15). In other words, God told Moses: You tell them that Yahweh sent you! At the heart of Gods answer are four facts about His nature for why the Israelites should believe the He could and would deliver them: Yahweh is self-existent and not dependent. God was unlike the Egyptian gods who were created by their own culture. Yahweh is the Elohim over elohims. The great I AM was bigger than the plight of the Israelites as He is greater than any trouble in our own lives. Yahweh is creator and sustainer. Who wrote the Law of Thermodynamics? Who governs the laws of gravity?Who grants the Sun permission to get up in the morning? Who gave the song for the birds to sing? Who owns the cattle on a thousand hills? Who brings men into power, raises nations into prominence and then brings them to naught? Is it not the great I AM who keeps His covenant promises. Yahweh is unchanging. Yahweh is the great I AM whose personality does not change. He does not suffer from a multi-personality disorder. He does not change with the ideas of his devotees. He is unmovable because He does not change. Because Yahweh is unchanging, He is constant unlike the gods of the Egyptians or whatever idol we may have set up in our own heart. Yahweh is eternal. Because He is the great I AM, Yahweh will never have a beginning nor will he ever have an end. Even though the fool has said there is no God, Yahweh is absolute reality with nothing before or after Him. The great I AM does not sleep, slumber, slack off, or slip into a daydream stupor. What God told Moses is this: Moses, you tell My people that the Covenant Keeper who promised their forefathers that He would make them into a great nation, would give them land as a nation, and would make them a blessing to the nations... you tell them the Faithful and Living One sent you! God keeps His promises because He alone is faithful even when we are not. Conclusion So, the question you may still be asking is whether it is or is not okay to be angry with God? Is it okay to be angry with He who is Holy and infinitely unlike us creatures? Is it okay to be angry with the One who sees and knows all things perfectly? Is it okay to be angry with the One who keeps His covenant promises because He is faithful while we are faithless time and time again? Is it okay to be angry with Yahweh who is Almighty God? As you know, God did use Moses to lead the Hebrews out of the bondage of slavery from Egypt, and He did it miraculously and profoundly. Yet, even after God delivered them, Moses found himself shepherding and leading a people who demonstrated over and over again just how faithless they really were. After their grievous sin of idolatry with the golden calf, Moses pleaded with God for mercy for His people who sinned, and God granted it. In Exodus 33:17-34:9 we are given a glimpse into Moses heart as a shepherd absolutely in love with Yahweh, and in that exchange asked to see God. God told Moses that he could not see His face and live, but this is what God did say He would do: I Myself will make all My goodness pass before you, and will proclaim the name of the Lord before you; and I will be gracious to whom I will be gracious, and will show compassion to whom I will show compassion (Exod. 33:19). When God did pass, He hid Moses in the cleft of a rock, and allowed His goodness to pass by him and when it did, Moses heard God proclaim of His goodness: The Lord, the Lord God, compassionate and merciful, slow to anger, and abounding in faithfulness and truth; who keeps faithfulness for thousands, who forgives wrongdoing, violation of His Law, and sin; yet He will by no means leave the guilty unpunished, inflicting the punishment of fathers on the children and on the grandchildren to the third and fourth generations (Exod. 34:67). So, what does Gods goodness include? It includes His mercy, patience, faithfulness, truth, and grace. But it also includes His justice and wrath in response to sin. So, again I ask you: Is it okay to be angry with the God who is Holy and infinitely unlike us creatures? Is it okay to be angry with the God who sees and knows all things perfectly? Is it okay to be angry with a holy God who is faithful while we are faithless time and time again? Is it okay to be angry with Yahweh who is Almighty God? Let me reframe the question for you: If God is infinitely good and we are the ones who need to improve upon being good, do we have any right to be angry with God? Now, think about the effects anger has on a relationship. When you are angry with someone because you believe you have been wronged by that person, it interferes with communication. Anger towards a friend or a member of your family often drives a wedge between you and that person. Anger typically results in the one offended distancing himself/herself from the person who wronged them. If there is no need for God to improve, especially in being good, then to suggest that it is okay to be angry with Him is to suggest that it is okay to accuse Him of wrongdoing. Psalm 145 is a great Psalm to visit while suffering or confused why God would allow you to suffer; verses 8-9 say the following: The Lord is gracious and compassionate; slow to anger and great in mercy. The Lord is good to all, and His mercies are over all His works. Again in Psalm 145:17-18, The Lord is righteous in all His ways, and kind in all His works. The Lord is near to all who call on Him, to all who call on Him in truth. I have head Christians and Pastors console the suffering and confused: It is okay to be angry with God. To which I ask, How is it okay to be angry with He who is infinitely holy, how is it okay to be angry with Him who sees all while my vision is limited, how is it okay to be angry with the Almighty whose faithfulness has been proven time and time again while my faithfulness has been found wanting more than I count? Listen dear friend, not only are we not given permission in all of Scripture to be angry with God, but we also have no right to be angry with Him. Here is what is permitted and even expected by God: We can be confused, frustrated, and even hurt emotionally. If God is infinitely good, which He is, then we can run to Him with our confusion, we can run to Him with our frustration, and we can run to Him with our wounded and bleeding hearts knowing that even though we cant see His goodness in and through our pain, we can trust that He is still good and will turn it around in His way and in His time for His glory and our good! After Moses experienced the goodness of God when His glory passed by while he was in the cleft of the rock, Moses responded on behalf of the sins of Israel: If in any way I have found favor in Your sight, Lord, please may the Lord go along in our midst, even though the people are so obstinate, and pardon our wrongdoing and our sin, and take us as Your own possession (Exod. 34:9). Dear brothers and sisters, if your faith and trust is in Jesus as proof of Gods infinite goodness, then my plea to you is not to run from Him in anger but to him with all your pain, confusion, and frustration. Run to the God of Romans 8:28-32, And we know that God causes all things to work together for good to those who love God, to those who are called according to His purpose. For those whom He foreknew, He also predestined to become conformed to the image of His Son, so that He would be the firstborn among many brothers and sisters; and these whom He predestined, He also called; and these whom He called, He also justified; and these whom He justified, He also glorified. What then shall we say to these things? If God is for us, who is against us? He who did not spare His own Son, but delivered Him over for us all, how will He not also with Him freely give us all things? [1] Sproul, R.C., The Holiness of God (Wheaton, IL: Tyndale House Publishers; 1998), 39.

Vancouver home prices took a sharp dive in January, hitting a two-year low, while Canada's GDP shrank in November, signaling potential economic trouble ahead. Adding to the uncertainty, looming tariffs could push housing costs even higher, leaving both buyers and sellers wondering what's next. If you're planning to enter the market in 2025, this episode is essential as we break down the data and what it means for you.The market is facing some serious headwinds and the threat of Tariffs is ever present. The potential for a 25% Tariff on key building materials like windows, drywall, and appliances would drive up construction costs, making new homes even more expensive. While a temporary 30-day pause has been put in place, tariffs could still take effect at any time. Earlier this week, when they seemed imminent, BMO's chief economist projected 0% GDP growth for 2025, 8% unemployment, and aggressive interest rate cuts down to 1.5%. The Canadian dollar briefly hit a 23-year low, and the 5-year bond yield dropped to a 30-month low, signaling lower mortgage rates ahead. In fact, 5-year fixed mortgage rates are already available at 3.89%, a sharp decline from last year.The BC Real Estate Association has painted a stark picture of what could happen if tariffs are imposed and Canada retaliates. They predict home sales could drop 30%, while active listings could rise 40%, leading to a more prolonged buyer's market. Mortgage rates could climb to 6% by 2026, and while prices are still expected to rise, they would increase at a much slower pace. With so much uncertainty, many buyers and sellers may wait on the sidelines, similar to the early days of the pandemic.At the same time, Vancouver's housing market is seeing some surprising shifts. January sales were up 9% year-over-year, marking the strongest January in three years. But new listings surged 46% compared to last year, reaching one of the highest January levels on record. Inventory is climbing quickly, hitting 11,100 active listings, a 33% increase over last year. The last time inventory was this high in January was 2019, a year when prices declined slightly. The sales-to-active listings ratio now sits at 14%, confirming that we remain in a balanced market, but momentum is shifting.Perhaps the biggest red flag is price movement. While the HPI benchmark price showed a slight increase in January, more immediate indicators tell a different story. Median prices dropped by $80,000, the largest single-month decline in 18 months, while average prices fell by $70,000, hitting their lowest level in two years. These sharp drops suggest that sellers may be adjusting expectations, while buyers hesitate to make moves in an uncertain environment.So, what's next? With sellers eager to offload properties and buyers waiting for more clarity on tariffs and interest rates, the spring market could be weaker than expected. Early February sales trends suggest a slower start, but as we approach the peak season, things could shift. Will prices stabilize, or are we heading into a prolonged downturn? Tune in as we analyze what's happening in Vancouver real estate and where the market might be headed next. _________________________________ Contact Us To Book Your Private Consultation:

Sheil Kapadia, Diante Lee, and Steven Ruiz kick off the show by reacting to Bill Belichick's proclamation that it's time to rename the Lombardi Trophy in Tom Brady's honor (00:00). Then, the guys discuss the floor, ceiling, and median outcomes for the Cowboys next season on the heels of the Brian Schottenheimer hire (03:02). Then, they do the same for the Raiders following their decision to bring in Pete Carroll (25:22). To round out the show, they take a look at potential offseason QB moves, how the Lions will fare without Ben Johnson (51:38), rumors of Kellen Moore to New Orleans (54:24), and some early thoughts on next weekend's Super Bowl matchup between the Chiefs and Eagles (59:58). The Ringer is committed to responsible gaming. Please visit www.rg-help.com to learn more about the resources and helplines available. Hosts: Sheil Kapadia, Diante Lee, and Steven Ruiz Producer: Troy Farkas Learn more about your ad choices. Visit podcastchoices.com/adchoices

Jak se v Česku dle dat žije a co můžeme zlepšit? Sociolog Daniel Prokop odhaluje, proč český vzdělávací systém prohlubuje nerovnosti, jak nastavit spravedlivější daňový systém a co Česko potřebuje, aby se posunulo vpřed. Dozvíte se: Proč nejsou ve vzdělání stejné šance? Proč současné daně škrtí ekonomiku a přesto vybereme málo peněz? Proč Praha bohatne a region chudnou? Jak zlepšit nedostupnost bydlení? Daniel Prokop je český sociolog. Dříve působil v agentuře Median a od roku 2019 vede vlastní výzkumnou organizaci PAQ Research. Zaměřuje se na témata chudoby a sociální nerovnosti v české společnosti. Je autorem knihy Slepé skvrny a podílí se na známých průzkumech a pravidelně vystupuje v českých médiích.

Ben and Nathan stress the importance of scoring above your target schools' LSAT medians. Read more on our website!Email daily@lsatdemon.com with questions or comments.Watch this episode on YouTube.

California faces an urgent housing crisis: Median home prices are double the national average and while in 2016 it was projected that the state needed to build 3.5 million new homes by 2025 to meet demand, just one quarter of those have even been permitted. Is building new cities from scratch the solution—or is it just a Silicon Valley pipe dream? Join us for an eye-opening fireside chat with Gabe Metcalf, head of planning at California Forever, exploring why he sees greenfield development, rather than infill alone, as our best shot at addressing the housing crisis. Drawing upon years in his previous role as CEO of SPUR and now leading urban planning for California Forever's controversial East Solano Plan—a proposed, VC-backed new city in Solano County—Metcalf will discuss why he believes that cities are humankind's greatest invention and why building walkable, compact communities must become a normal form of development. Is it time to rethink our approach to building mass housing or will hurdles mean new cities never break ground? An essential discussion for residents, urban planners, environmental advocates and anyone invested in the Bay Area's housing future. Learn more about your ad choices. Visit megaphone.fm/adchoices

Thank you for joining us for our 2nd Cabral HouseCall of the weekend! I'm looking forward to sharing with you some of our community's questions that have come in over the past few weeks… Jenny: Hi Dr. Cabral, First, thank you to you and your amazing team for selflessly giving of your time and knowledge so we can all learn and grow on our health journeys. We can't really express this enough. I have a question about your Alkalizing Vitamin C product. You've recommended this as something to take in water upon waking, but could it also be effective when I add it to my morning smoothie or is it better to take separately? I don't enjoy the taste on its own, so I'm unlikely to drink it just in water. Any suggestions? Thanks!   Kavita: Hello Dr. Cabral, First, I want to thank you for your amazing work! I listen to your podcast every day, which means I've been consistently listening for the past 3,231 days! :) I have an important question for you. I recently started taking Berberine, but a friend mentioned that it may have adverse reactions. She told me about her neighbor, who had to stop taking it because doctors wouldn't perform surgery on her while she was using Berberine. I'm unsure of the exact details, but it raised some concerns. I started taking Berberine because there's diabetes in my family, and I'm hoping to avoid getting on any medications as I move ahead in life. How do I make sure it is working for me? I hope this gets on your list soon :) Thank you, Kavita ( Pronounced - ka-vee-tha)    Jenni: Hi, I've been battling Meibomian Gland Disorder for over a year. The only thing that has provided relief has been taking 50mg daily of doxycycline. I've been on this dosage for 10 months. My doctor has tried weaning me off, but the symptoms pop back up after 4-5 days. Nobody seems to understand why this issue arose suddenly, and no one can offer me help outside of antibiotics. Do you have any experience in helping patients with MGD? Could this be due to heavy metals, gut issues, systemic inflammation? I'm desperate for natural relief. Thank you, Jenni   Michael: Hi Dr. Cabral. Thank you for the work you do and especially taking time to answer people's questions. My question is regarding to home oil as the main heating source. What are your thoughts on the cleanest and safest option? We currently have the standard heating oil. There is an option to change the oil to a B50 blend which consists of a 50/50 blend of standard heating oil and biodiesel. This would then convert to a B99 fuel which is 99% biodiesel. Any thoughts on this subject or know of a place I can go to research more? Thank you!   Paedyn: Hi Dr Cabral, but of a hard to question. What are some ways I can naturally treat MALS (median arcuate ligament syndrome). I woke up randomly with stomach pain in my epigastric region one day out of nowhere and Dr's are saying it's this and that the only treatment option is very major surgery which only a select handful of surgeons perform this surgery worldwide and a lot of people end up worse off after the surgery. I just want to heal my body naturally. Thank you so much! Thank you for tuning into this weekend's Cabral HouseCalls and be sure to check back tomorrow for our Mindset & Motivation Monday show to get your week started off right! - - - Show Notes and Resources: StephenCabral.com/3264 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!